Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $661.7600 (0.58%) ($647.4100 - $661.7600) on Fri. May. 20, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.65% (three month average) | RSI | 52 | Latest Price | $661.7600(0.58%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.5% a day on average for past five trading days. | Weekly Trend | REGN advances 1.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(57%) DIA(39%) IWD(37%) SPLV(36%) XLV(36%) | Factors Impacting REGN price | REGN will decline at least -0.825% in a week (0% probabilities). VIXM(-14%) TBT(-11%) UUP(-6%) VXX(-2%) USO(1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.825% (StdDev 1.65%) | Hourly BBV | -0.7 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $659.97(0.27%) | 10 Day Moving Average | $642.09(3.06%) | 20 Day Moving Average | $650.17(1.78%) | To recent high | -10.4% | To recent low | 10.3% | Market Cap | $70.166b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |